top of page

EC approves Opdivo + Yervoy regimen for advanced melanoma

The European Commission (EC) has approved Bristol-Myers Squibb’s Opdivo in combination with Yervoy for the treatment of advanced (unresectable or metastatic) melanoma in adults.

Click on this link for more information.



Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page